Streetbeat News

Stock Prices

AOS

ENPH

MCD

MEDP

TFII

Top Wall Street analysts have downgraded several major stocks, including McDonald's, TFI International, Enphase Energy, A.O. Smith, and Medpace Holdings. These downgrades reflect a shift in analyst sentiment and could impact stock prices in the short term.

Portfolio Pulse from Avi Kapoor

October 23, 2024 | 12:21 pm

CNSP

CNS Pharmaceuticals has requested a hearing with a panel on November 5, 2024, to halt the suspension or delisting of its stock pending a decision.

Portfolio Pulse from Benzinga Newsdesk

October 23, 2024 | 12:16 pm

ABOS

Acumen Pharmaceuticals will present a late-breaking presentation at the 17th Annual Clinical Trials on Alzheimer's Disease Conference. The presentation will focus on the use of a validated pTau217 assay in the participant screening process for their Phase 2 ALTITUDE-AD study of sabirnetug for early Alzheimer's disease.

Portfolio Pulse from Benzinga Newsdesk

October 23, 2024 | 12:13 pm

TRUG

TruGolf Holdings shares are experiencing an increase in trading activity following the company's announcement of revenue growth guidance for the second half of the year.

Portfolio Pulse from Benzinga Newsdesk

October 23, 2024 | 12:13 pm

PIXY

ShiftPixy shares rose following the announcement of a letter of intent to acquire TurboScale.

Portfolio Pulse from Benzinga Newsdesk

October 23, 2024 | 12:11 pm

GANX

Gain Therapeutics presented data on their allosteric inhibitors targeting DDR2 at the EORTC-NCI-AACR Symposium. Their compound, GT-03842, shows promise in oncology by hindering DDR2 phosphorylation and activation, potentially offering advantages over traditional kinase inhibitors.

Portfolio Pulse from Benzinga Newsdesk

October 23, 2024 | 12:11 pm

TELA

TELA Bio has announced a public offering of 12 million shares at $2.25 per share and pre-funded warrants for 5.8 million shares at $2.2499 each, aiming to raise $40 million in gross proceeds.

Portfolio Pulse from Benzinga Newsdesk

October 23, 2024 | 12:11 pm

DBVT

DBV Technologies shares rose following regulatory updates for their Viaskin Peanut patch in the US and Europe.

Portfolio Pulse from Benzinga Newsdesk

October 23, 2024 | 12:10 pm

UPXI

Upexi, Inc. (NASDAQ:UPXI) has regained compliance with Nasdaq's minimum bid price rule after maintaining a closing bid price of $1.00 or greater from October 3 to October 16, 2024. The company plans to file its delayed Form 10-K by November 1, 2024.

Portfolio Pulse from Benzinga Newsdesk

October 23, 2024 | 12:09 pm

ORIC

Oric Pharmaceuticals shares rose after the company presented promising data on ORIC-114 for treating specific cancer mutations at a major symposium.

Portfolio Pulse from Benzinga Newsdesk

October 23, 2024 | 12:09 pm